Clinical Integration of Genetic Risk Assessment in Family Medicine
Public ClinicalTrials.gov record NCT00339794. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study, conducted by the American Academy of Family Physicians (AAFP) and the National Human Genome Research Institute, will characterize family physicians' attitudes and practices related to the genetics of complex disorders. As the front line of care for most Americans, family medicine will have a central role in seeing that new findings in genetics lead to disease prevention and health improvements. The information gained from this study could be useful in understanding and shaping the dissemination of genetic medicine in ways that improve the standard of primary care practice. Members of the AAFP will be randomly selected from the organization's membership records to be invited to participate in this two-phase study. The first phase is a web-based survey of AAFP members. In the second phase, a sub-sample of those who complete the survey will be re-contacted; half will be members who have enrolled in a year-long web-based curriculum related to medical genetics, and the other half will be those who have chosen not to enroll in the curriculum. Survey questions relate to the physicians' practices, knowledge, and opinions about implications of genomic medicine. Survey areas include family history taking; opinions about the future of genetics and family medicine; information about the physician and his or her practice; and physician's skills, attitudes and knowledge.
Study identification
- NCT ID
- NCT00339794
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,500 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 6, 2004
- Primary completion
- Not listed
- Completion
- Jul 15, 2010
- Last update posted
- Jul 1, 2017
2004 – 2010
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Human Genome Research Institute (NHGRI), 9000 Rockville Pike | Bethesda | Maryland | 20892 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00339794, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2017 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00339794 live on ClinicalTrials.gov.